Cytotoxicity of silica nanoparticles on HaCaT cells

Journal of Applied Toxicology

Volumn 34, Issue 4, 2014, Pages 367-372

  Liang, Hao ^a   Jin, Chan ^b,c   Tang, Ying ^c   Wang, Fude ^b   Ma, Chunwang ^a   Yang, Yongji ^c  

^a HENAN NORMAL UNIVERSITY   (China)

^b SHANGHAI INSTITUTE OF APPLIED PHYSICS   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cytotoxicity; HaCaT cells; Oxidative stress; Silicon dioxide nanoparticles; Transmission electron microscope (TEM)

Indexed keywords

ANTIOXIDANT; GLUTATHIONE; NANOPARTICLE; REACTIVE OXYGEN METABOLITE; SILICA NANOPARTICLE; SILICON DIOXIDE; UNCLASSIFIED DRUG;

ARTICLE; AUTOPHAGOSOME; CELL DAMAGE; CELL IMMORTALIZATION; CELL LINE; CELL MEMBRANE; CELL VIABILITY; CONTROLLED STUDY; CYTOPLASM; CYTOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; KERATINOCYTE; LYSOSOME; OXIDATIVE STRESS; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN DEPLETION;

CYTOTOXICITY; HACAT CELLS; OXIDATIVE STRESS; SILICON DIOXIDE NANOPARTICLES; TRANSMISSION ELECTRON MICROSCOPE (TEM);

AUTOPHAGY; CELL CULTURE TECHNIQUES; CELL LINE; CELL MEMBRANE; CELL SURVIVAL; CYTOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; KERATINOCYTES; LYSOSOMES; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; OXIDATIVE STRESS; SILICON DIOXIDE;

EID: 84893664207     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.2953     Document Type: Article

References (35)

1. 2 particles in HeLa cells. Arch. Toxicol. 85:813-826.
2. Auffan M, Rose J, Bottero JY, Lowry GV, Jolivet JP, Wiesner MR. 2009. Towards a definition of inorganic nanoparticles from an environmental, health and safety perspective. Nat. Nanotechnol. 4:634-641.
3. Bharali DJ, Klejbor I, Stachowiak EK. 2005. Organically modified silica nanoparticles a nonviral vector for in vivo gene delivery and expresSiOn in the brain. Proc. Natl. Acad. Sci. U. S. A. 102:11539-11544.
4. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE. 1988. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 106:761-771.
5. Conner SD, Schmid SL. 2003. Regulated portals of entry into the cell. Nature 422:37-44.
6. Czarnobaj K, Lukasiak J. 2007. In vitro release of cisplatin from sol-gel processed organically modified silica xerogels. J. Mater. Sci. Mater. Med. 18:2041-2044.
7. Gratton SE, Ropp PA, Pohlhaus PD. 2008. The effect of particle design on cellular internalization pathways. Proc. Natl. Acad. Sci. U. S. A. 105:11613-11618.
8. Gupta AK, Gupta M. 2005. Cytotoxicity suppresSiOn and cellular uptake enhancement of surface modified magnetic nanoparticles. Biomaterials 26:1565-1573.
9. Gupta AK, Berry C, Gupta M, Curtis A. 2003. Receptor-mediated targeting of magnetic nanoparticles using insulin as a surface ligand to prevent endocytosis. IEEE Trans. Nanobioscience 2:255-261.
10. Huang X, Teng X, Chen D, Tang F, He J. 2010. The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function. Biomaterials 31:438-448.
11. Kim JS, Yoon TJ, Yu KN. 2006. Cellular uptake of magnetic nanoparticle is mediated through energy-dependent endocytosis in A549 cells. J. Vet. Sci. 7:321-326.
12. Kim S, Ohulchanskyy TY, Pudavar HE, Pandey RK, Prasad PN. 2007. Organically modified silica nanoparticles co-encapsulating photosensitizing drug and aggregation-enhanced two-photon absorbing fluorescent dye aggregates for two-photon photodynamic therapy. J. Am. Chem. Soc. 129:2669-2675.
13. 2 nanoparticles in anatase and rutile crystal phase. Biol. Trace Elem. Res. 141:3-15.
14. Jin Y, Kannan S, Wu M, Zhao JX. 2007. Toxicity of luminescent silica nanoparticles to living cells. Chem. Res. Toxicol. 20:1126-1133.
15. Lin W, Huang YW, Zhou XD, Ma Y. 2006. In vitro toxicity of silica nanoparticles in human lung cancer cells. Toxicol. Appl. Pharmacol. 217:252-259.
16. Lison D, Thomassen LC, Rabolli V. 2008. Nominal and effective dosimetry of silica nanoparticles in cytotoxicity assays. Toxicol. Sci. 104:155-162.
17. Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65:55-63.
18. Napierska D, Thomassen LC, Rabolli V, et al. 2009. Size-dependent cytotoxicity of monodisperse silica nanoparticles in human endothelial cells. Small 5:846-853.
19. Nel A, Xia T, Madler L, Li N. 2006. Toxic potential of materials at the nanolevel. Science 311:622-627.
20. 60) induce oxidative stress in the brain of juvenile largemouth bass. Environ. Health Perspect. 112:1058-1062.
21. Oberdorster G, Oberdorster E, Oberdorster J. 2005. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. 113:823-839.
22. Ohulchanskyy TY, Roy I, Goswami LN, et al. 2007. Organically modified silica nanoparticles with covalently incorporated photosensitizer for photodynamic therapy of cancer. Nano Lett. 7:2835-2842.
23. Park EJ, Park K. 2009. Oxidative stress and pro-inflammatory responses induced by silica nanoparticles in vivo and in vitro. Toxicol. Lett. 184:18-25.
24. Park MV, Annema W, Salvati A, et al. 2009. In vitro developmental toxicity test detects inhibition of stem cell differentiation by silica nanoparticles. Toxicol. Appl. Pharmacol. 240:108-116.
25. Peters K, Unger RE, Kirkpatrick CJ, Gatti AM, Monari E. 2004. Effects of nano-scaled particles on endothelial cell function in vitro: studies on viability, proliferation and inflammation. J. Mater. Sci. Mater. Med. 15:321-325.
26. Qhobosheane M, Santra S, Zhang P, Tan W. 2001. Biochemically functionalized silica nanoparticles. Analyst 126:1274-1278.
27. Rieux A, Fievez V, Garinot M, Schneider YJ, Preat V. 2006. Nanoparticles as potential oral delivery systems of proteins and vaccines a mechanistic approach. J. Control. Release 116:1-27.
28. Roy I, Ohulchanskyy TY, Bharali DJ, et al. 2005. Optical tracking of organically modified silica nanoparticles as DNA carriers a nonviral, nanomedicine approach for gene delivery. Proc. Natl. Acad. Sci. U. S. A. 102:279-284.
29. Seaton A, Tran L, Aitken R, Donaldson K. 2010. Nanoparticles, human health hazard and regulation. J. R. Soc. Interface 1:S119-129.
30. Vasir JK, Labhasetwar V. 2008. Quantification of the force of nanoparticle-cell membrane interactions and its influence on intracellular trafficking of nanoparticles. Biomaterials 29:4244-4252.
31. 2 particles in cultured human lymphoblastoid cells. Mutat. Res. 628:99-106.
32. Waters KM, Masiello LM, Zangar RC. 2009. Macrophage responses to silica nanoparticles are highly conserved across particle sizes. Toxicol. Sci. 107:553-569.
33. Wilhelm C, Billotey C, Roger J, Pons JN, Bacri JC, Gazeau F. 2003. Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating. Biomaterials 24:1001-1011.
34. Yang H, Liu C, Yang D, Zhang H, Xi Z. 2009. Comparative study of cytotoxicity, oxidative stress and genotoxicity induced by four typical nanomaterials: the role of particle size, shape and composition. J. Appl. Toxicol. 29:69-78.
35. 2 nanoparticles induce cytotoxicity and protein expresSiOn alteration in HaCaT cells. Part. Fibre Toxicol. 7:1.